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Calcium/calmodulin-dependent kinase II (CaMKII)
forms a highly conserved dodecameric assembly
that is sensitive to the frequency of calcium pulse
trains. Neither the structure of the dodecameric
assembly nor how it regulates CaMKII are known.
We present the crystal structure of an autoinhibited
full-length human CaMKII holoenzyme, revealing
an unexpected compact arrangement of kinase
domains docked against a central hub, with the
calmodulin-binding sites completely inaccessible.
We show that this compact docking is important for
the autoinhibition of the kinase domains and for
setting the calcium response of the holoenzyme.
Comparison of CaMKII isoforms, which differ in the
length of the linker between the kinase domain and
the hub, demonstrates that these interactions can
be strengthened or weakened by changes in linker
length. This equilibrium between autoinhibited states
provides a simple mechanism for tuning the calcium
response without changes in either the hub or the
kinase domains.
INTRODUCTION
Calcium/calmodulin-dependent kinase II (CaMKII) is unique
among protein kinases because it forms a dodecameric holoen-
zyme that responds not just to the amplitude but also to the732 Cell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc.frequency of the activating signal. CaMKII is of central impor-
tance in neuronal signaling because it transduces intracellular
calcium influx into the phosphorylation of ion channels, resulting
in changes that alter synaptic strength (Kennedy et al., 1983;
Nairn et al., 1985; Schulman and Greengard, 1978). The activity
of CaMKII is switched on by calcium spikes, but the enzyme
escapes calcium dependence when the calcium spike frequency
exceeds a characteristic threshold.
Calcium/calmodulin (Ca2+/CaM) activates CaMKII by displac-
ing an inhibitory segment that blocks the active site of the
enzyme. This segment is phosphorylated in a frequency-depen-
dent manner, and once phosphorylated it no longer blocks the
enzyme, even in the absence of Ca2+/CaM (De Koninck and
Schulman, 1998; Hanson et al., 1989; Miller and Kennedy,
1986). In this way, the enzyme is capable of storing a molecular
‘‘memory’’ of activating pulse trains, a property responsible for
the key role played by CaMKII in the acquisition of long-term
potentiation (LTP) (Malenka and Bear, 2004).
Each subunit of a CaMKII holoenzyme consists of a Ser/Thr-
specific kinase domain followed by a regulatory segment that
binds to Ca2+/CaM (Hudmon and Schulman, 2002) (Figure 1).
The regulatory segment is followed by a flexible linker of variable
length that connects to the hub domain (also referred to as the
association domain). The hub domains assemble into two hex-
americ rings that form the dodecameric holoenzyme (Hoelz
et al., 2003; Rellos et al., 2010; Shen and Meyer, 1998).
Several structures of the isolated kinase domain, determined
previously, illustrate how the regulatory segment controls kinase
activity (Figure S6 available online). Three critical phosphoryla-
tion sites (Thr286, Thr305, and Thr306) are located within the
regulatory segment, which is divided into three regions denoted
Figure 1. CaMKII Subunit Architecture and Activation
(A) Domain architecture of an individual CaMKII subunit: the kinase domain (blue) is followed by a regulatory segment (yellow and burgundy), a variable linker
region (dark blue), and the hub domain (gray). The regulatory segment is comprised of the R1 element (containing the autophosphorylation site Thr286), the R2
element (an intramolecular clamp that docks the regulatory segment), and the calmodulin-binding region, R3. The calmodulin-binding footprint overlaps R3 and
a portion of R2 (burgundy).
(B) Activation of subunits in the holoenzyme proceeds via regulatory segment displacement by Ca2+/CaMbinding to enable access and presentation of Thr286 for
phosphorylation by other subunits.
(C) Structure of an individual CaMKII subunit in the crystallized holoenzyme. The regulatory segment (yellow) extends from the C terminus of the kinase domain in
an a helix, then dissolves and makes a tight turn to incorporate itself into the b sheet of the hub domain.
See also Figure S1 and Figure S6.R1, R2, and R3 (see Figure 1A). Thr286 (mouse a isoform
numbering) is at the base of an a helix formed by the regulatory
segment. This a helix blocks substrate binding in the autoinhi-
bited structure by occupying a hydrophobic groove on the
kinase domain. Thr305 and Thr306 lie at the heart of the calmod-
ulin-binding region of the regulatory segment (the R3 element).Phosphorylation at Thr286 occurs in trans, between two kinase
subunits of the same holoenzyme (Hanson et al., 1994), and
disrupts the docking of the R1 and R2 elements of the regulatory
segment against the kinase domain (Figure 1B). This releases
autoinhibition, even in the absence of calcium, thereby confer-
ring calcium-independent activity to the kinase. PhosphorylationCell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc. 733
of Thr305 and Thr306 prevents calmodulin binding (Colbran,
1993; Hanson and Schulman, 1992). Studies using transgenic
mice show that mutation of Thr286, a site of phosphorylation in
the regulatory segment, results in impaired learning, whereas
mutation of the two other phosphorylation sites (Thr305 and
Thr306) results in learning that is less adaptable (Elgersma
et al., 2002; Silva et al., 1992).
There are four CaMKII genes (a, b, g, d) in humans. The
enzymes produced by these genes have virtually identical kinase
domains (95% sequence identity) and very similar hub
domains (80% identity). The principal difference between
these gene products is in the linker connecting the kinase
domain to the hub domain, which is variable in both sequence
and length. At least 38 distinct mammalian splice variants are
generated by lengthening or shortening this region (Tombes
et al., 2003), and changes in the linker length are correlated
with changes in the frequency response of the enzyme (Bayer
et al., 2002). The origin of the coupling between linker length
and the frequency response is unclear.
All of the essential features of CaMKII are conserved across
metazoans. The regulatory segment and the three phosphoryla-
tion sites within it are invariant. The residues that mediate the
oligomerization of the hub domain are conserved from represen-
tatives of the earliest metazoans, such as hydra and sea urchins,
to humans (Figure S1). This conservation in CaMKII dates to the
evolutionary stage when the first synapse was thought to have
formed (Ryan and Grant, 2009). The linker region between the
regulatory segment and hub domain is the only major site of
variation over the 1200 million year evolution of this enzyme.
Some information about the quaternary structure of the
CaMKII holoenzyme assembly has emerged from electron
microscopy (EM) and small-angle X-ray scattering (SAXS). In
one set of EM reconstructions, individual kinase domains are
arranged above and below the midplane of the central hub
(Kolodziej et al., 2000; Woodgett et al., 1984). In another set of
EM reconstructions, the kinase domains occupy radial positions
at the midplane of the central hub and are in close proximity to
one another (Morris and To¨ro¨k, 2001). The radial arrangement
of kinase domains in this set of EM reconstructions is similar to
that seen in models of CaMKII based on SAXS (Rosenberg
et al., 2005). These disparate views of the holoenzyme structure
have not been reconciled.
We now present the crystal structure of the full-length dodeca-
meric human isoform of CaMKII in an autoinhibited state. This
structure reveals an unanticipated and very compact arrange-
ment of kinase domains around the central hub. A portion of
the regulatory segment, bearing the phosphorylation sites
Thr305 and Thr306, is incorporated into the tertiary structure of
the subunits of the central hub. We present SAXS and biochem-
ical data indicating that the compact conformation of the holoen-
zyme seen in the crystal is present in solution and that the
equilibrium between compact and extended forms is altered
by changing the length of the linker. Analysis of a stochastic
kinetics computational model for CaMKII shows that alterations
in the equilibrium constant between the compact and extended
forms of the holoenzyme can alter the frequency response of
the enzyme. Based on these observations, we propose that a
dynamic equilibrium between compact and extended autoinhi-734 Cell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc.bited states modulates CaMKII autoinhibition to set a tunable
threshold for the response to calcium spikes.
RESULTS AND DISCUSSION
Crystallography and Structure Determination
We determined the crystal structure of an essentially full-length
variant of the human CaMKII holoenzyme (residues 7–444, with
the first six residues deleted) at a resolution of 4.0/3.6 A˚ (see
Table S1). Crystallization utilized the kinase inhibitor bosutinib,
previously shown to bind to CaMKII (Puttini et al., 2006; Rix
et al., 2010). The b7 isoform lacks an extended linker, which in
other isoforms can be as long as 50 residues (the a isoform
with the b7 linker crystallized will be referred to here as the
‘‘short-linker’’ construct) (Wang et al., 2000). We inactivated
the kinase domain by mutation (K42M, D135N) and replaced
one phosphorylation site (Thr306) by valine.
The crystals contain one CaMKII subunit in the asymmetric
unit, with the dodecameric holoenzyme generated by the 622
symmetry of the crystal lattice (Figure 2). These crystals dif-
fracted X-rays anisotropically, with strong data extending to
4.0 A˚ in all directions and with weak data to 3.6 A˚ in the a* and
b* directions. The X-ray data beyond 4 A˚ are veryweak, but inclu-
sion of these data resulted in noticeable improvement in electron
density maps (Figure S2D), so these data were retained. Despite
limitations in the resolution of the X-ray data, the structure of the
holoenzyme assembly could be determined reliably because
high-resolution structures are available for the individual kinase
and hub domains (Chao et al., 2010; Hoelz et al., 2003; Rellos
et al., 2010; Rosenberg et al., 2005). The holoenzyme structure
(Figure 2) was determined by molecular replacement using
search models based on the C-terminal lobes of the kinase
domain and the hub domain (PDB codes: 2VN9 human d isoform
and 2UX0 human g isoform, respectively). The initial solution
yielded electron density maps with clear density for the
N-terminal lobe of the kinase domain, which was positioned
manually. The current model has been refined to an R value of
27.3% and a free R value of 32.7% (Table S1). The analysis pre-
sented in this paper is restricted to features that are resolved
unambiguously in the electron density maps.
An important and unanticipated aspect of the structure is the
incorporation of a portion of the regulatory segment (residues
304–308, including the autophosphorylation sites Thr305 and
Thr306) as an additional strand into the central b sheet of the
hub domain (Figure 3). This b strand was clearly visible in the
initial electron density maps, and the structure of this strand
could be modeled unambiguously (Figure S2B). Electron density
for the loops that connect this strand to the rest of the regulatory
segment was not well resolved initially, so we utilized the kine-
matic loop closure method (Mandell et al., 2009) to generate
models for these regions (residues 299–304 and residues 309–
314) of the regulatory segment (see Experimental Procedures).
The precise structure of these loops does not enter into the
analysis presented here.
Architecture of the Holoenzyme
The two stacked hexameric rings of hub domains form the core
of the holoenzyme assembly and are arranged essentially as
Figure 2. Domain Architecture of the Dodecameric CaMKII Holoenzyme
The holoenzyme assembly comprises kinase domains tightly arranged about the central hub domain. Each kinase domain occupies a position between two hub
domain subunits, with its active site pointed toward the center of the assembly. The arrangement forms two separate hexameric rings of kinase ‘‘petals’’ that fold
against the central hub. See also Figure S2 and Figure S3.
Cell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc. 735
736 Cell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc.
described previously (Hoelz et al., 2003; Rellos et al., 2010). Each
kinase domain is positioned between two subunits of the central
hub, one of which is the hub subunit to which it is connected
covalently. The connections are shown in Figure 2, in which
the subunits in the upper ring are namedA through F in a counter-
clockwise sense. The kinase domain of subunit B interacts with
the hub domains of subunits A and B, and so on around the
ring. This arrangement creates two sets of six kinase domain
‘‘petals,’’ one above the hub and one below, that fold against
the central hub.
The quaternary assembly of the holoenzyme seen in the
crystal structure has some similarity to the EM reconstructions
that have kinase domains arranged above and below the mid-
plane of the central hub (Kolodziej et al., 2000). These EM recon-
structions have the kinase domains at extended positions, far
from each other and from the central hub (these holoenzyme
reconstructions have a roughly cylindrical shape of 200 A˚
height and 140 A˚ diameter). In contrast, the kinase domains in
the crystal structure pack tightly against the central hub (the
assembly in the crystals has a cylindrical height of 100 A˚ and
a diameter of 150 A˚).
The R3 element of the regulatory segment connects to the
hub domain. Although the R3 element is sandwiched between
the kinase domain and the hub domain, the point of linkage to
the hub domain occurs at the surface of the holoenzyme. This
means that the extra residues present in CaMKII isoforms with
longer linkers can be readily accommodated without disturbing
the architecture of the holoenzyme (Figure S3C). This arrange-
ment projects the linker regions from a central midplane of the
holoenzyme, spacing linker extensions 24 and 33 A˚ apart to
create an accessible multivalent interaction surface for binding
partners.
Structure of an Autoinhibited CaMKII Subunit
Each subunit of the CaMKII holoenzyme in the crystal structure
comprises a bosutinib-bound kinase domain to which the hub
domain is docked tightly (Figure 1C). The conformation of the
kinase domain is very similar to that seen previously for the auto-
inhibited form of the human d isoform (Rellos et al., 2010), and the
interaction with the hub domain appears to involve very little
induced fit on the part of the kinase domain. The hub domain
is arranged so that it sandwiches the regulatory segment
between it and the C lobe of the kinase domain, and it makes
extensive contacts with the N lobe of the kinase domain. In the
standard view of the kinase domain (Figure 1C), the hub domain
is located somewhat in front of the kinase domain. An adjacent
hub domain from another subunit in the holoenzyme is posi-
tioned behind the first one, such that each kinase domain inter-Figure 3. Autoinhibitory Interactions
(A) The calmodulin recognition elements are completely sequestered in each auto
subunit with kinase and hub domains. Right, a zoomed-in surface representation
interactions from the kinase and association domains (cyan and gray, respective
(B) The b clip interaction. The central portion of the regulatory segment recogn
b strand. Thr306 (mutated to valine in the crystallization construct) interacts with
(C) The hub domain spur. The docking interaction between the kinase domain an
activation loop (green) and at a spur in the hub domain.
See also Figure S3.acts with two hub domains (Figure 3). The two hub domains
together bury 2400 A˚2 of surface area at the interfaces with
the kinase domain, with the contributions from the cis- and
trans-interactions being 900 and 1500 A˚2, respectively.
The formation of the cis-interface between the kinase domain
and the hub domain makes the entire calmodulin recognition
element inaccessible to calmodulin (Figure 3A). The R1 element
of the regulatory segment exits the base of the kinase domain
and continues into the R2 element to form an a helix (residues
284–300). As in other CaMKII structures, this helix abuts helix
aD and locks the kinase in an inactive conformation (Figure S6).
In the holoenzyme, unlike in structures of the isolated kinase
domains, the R3 element is partially unfolded and makes a tight
turn to interact with the hub domain.
Residues 304–308 of the R3 element form a b strand that is
incorporated into the highly twisted b sheet within the core of
the hub domain (Figure 3B). We refer to this interaction between
the R3 element of the regulatory segment and the hub domain
as the b clip. The b clip utilizes several hydrophobic residues
that are strictly conserved across metazoans (Figure S1). Most
notably, Thr306 (mutated to Val in the crystallization construct)
lies at the heart of the b clip and interacts with Ile321, Ile384,
Leu385, and Pro387 to pull the kinase domain tight against the
hub domain. The presence of Thr306 at the core of the b clip
predicts that phosphorylation of Thr305 and Thr306 would be
incompatible with this autoinhibited form of the holoenzyme.
Thr305 and Thr306 are within the calmodulin recognition
element, and phosphorylation of these residues is known to
prevent calmodulin rebinding (Colbran, 1993; Hanson and
Schulman, 1992). Our structure now indicates that phosphoryla-
tion of these sites will also prevent adoption of the closed form of
the holoenzyme in the absence of Ca2+/CaM.
Kinase Domain-Central Hub Docking Interactions
An unanticipated aspect of the holoenzyme structure are the
extensive interactions between the kinase domains and the
central hub (Figure 3). In addition to the incorporation of the R3
portion of the regulatory segment into the hub domain, there
are interactions between the kinase domain and a ‘‘spur’’ on
an adjacent hub domain (Figure 3C and Figure 2). The hub
domain spur docks against the activation loop of the adjacent
kinase domain, thereby blocking access to the substrate-
binding site. This interaction is analogous to the interaction
between the catalytic domain of protein kinase A and its regula-
tory domain (Kim et al., 2007) (Figure S3).
The importance of the trans-interaction for CaMKII regulation
is supported by the fact that residues comprising the hub domain
spur interface are conserved from hydra to man. A sensitizationinhibited CaMKII subunit of the holoenzyme. Schematic of an individual kinase
of a subunit with the regulatory segment (yellow and burgundy) embraced by
ly).
ized by calmodulin is incorporated into the hub domain b sheet as a parallel
a hydrophobic pocket in the hub domain.
d the adjacent hub domain subunit is mediated by residues at the base of the
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screen in C. elegans for mutants that suppress seizures identi-
fied activating mutations in CaMKII at the base of the activation
loop (LeBoeuf et al., 2007). One of these mutations (G172E)
maps to the center of the hydrophobic interactions at the hub
domain spur interface and would be predicted to destabilize
the packing of kinase domains in the autoinhibited holoenzyme
arrangement that we observe (Figure S3).
Mutation of Residues at the Kinase-Hub Interfaces
Alters the Activation of Human Short-Linker CaMKII
The human short-linker CaMKII construct is activated coopera-
tively by Ca2+/CaM (Hill coefficient, nH of 2.1) with an EC50
(concentration at half-maximal velocity) value of 6.0 mM (Fig-
ure 4A). This EC50 value for the human short-linker construct is
much higher than that for isoforms with longer linkers (typically
around 25 nM), consistent with a strengthening of autoinhibi-
tion due to shortening of the linker. When the b clip region in
the hub domain is mutated in the human short-linker constructs
(I321E), the EC50 value is shifted to 30 nM (Figure 4A). We
find similar effects with mutations in the hub domain spur (Fig-
ure S4A). In addition, we also observe an elimination of cooper-
ative activation in these mutants, with nH 1.0.
We investigated whether the docking interactions observed
in the crystal structure influence the frequency-dependent
autophosphorylation at Thr286. Utilizing a modified version of
the device developed for the first in vitro studies of the CaMKII
frequency response (De Koninck and Schulman, 1998), we
monitored the frequency-dependent acquisition of Ca2+ inde-
pendence (‘‘autonomy,’’ see Experimental Procedures). Ca2+/
CaM-independent autonomous activity reflects Thr286 phos-
phorylation and is reported as a percentage of calcium-depen-
dent activity. We measured the acquisition of Ca2+-independent
activity of a human ‘‘long-linker’’ construct (a human a isoform of
CaMKII with a 30 residue linker) in response to different frequen-
cies of 100 ms pulses of 8 mM calmodulin (total exposure time of
6 s) and observed an exponential increase in Ca2+-independent
activity with respect to frequency, as shown previously (Fig-
ure 4B) (De Koninck and Schulman, 1998).
It has been observed that linker length alters the extent of
Ca2+-independent activity that is generated at a particular
frequency (Bayer et al., 2002). We measured the Ca2+-indepen-
dent activity of the human short-linker construct and the human
short-linker construct with a central hub mutation (I321E) under
the basal conditions described above and observed no acquisi-
tion of Ca2+-independent activity for either construct. We inves-
tigated the activation rates of these constructs by varying the
pulse duration, from 100 ms (as mentioned above) to 350 ms.
Under saturating calmodulin concentrations (12 mM), both
proteins acquire Ca2+-independent activity with a linear depen-
dence on pulse duration. At low calmodulin concentrations
(100 nM) there is no activation observed for the duration
range tested. At intermediate calmodulin concentrations (2 and
3 mM), the short-linker mutant (I321E) displays 2-fold higher
activity compared to the short-linker construct at 350 ms pulse
duration (Figure 4C). Under these conditions, the long-linker iso-
form acquires 100%Ca2+-independent activity (data not shown).
These experiments show that mutation of the interface between
the kinase and the hub potentiates activation, suggesting that738 Cell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc.the kinase-hub interactions are important for autoinhibition and
for setting the threshold frequency for activation.
Conformational Interconversion in the Human
Short-Linker CaMKII
To address the discrepancy between the compact structure of
the holoenzyme seen in our crystallographic analysis and the
previously published EM and SAXS reconstructions, we
measured SAXS data on several constructs of CaMKII. Solution
scattering curves for the human short-linker construct and the
crystallization construct (the human short-linker CaMKII with
mutations K42M, D135N, and T306V and the inhibitor bosutinib)
are superimposable, and the values for the radius of gyration (Rg)
derived from both sets of data are 61 A˚. This indicates that
the structure of the holoenzyme is not altered substantially by
the mutations and the addition of bosutinib (Figure S5A). We
compared the experimental scattering data for this construct
with theoretical scattering curves calculated from the crystal
structure using the program CRYSOL (Svergun et al., 1995) (Fig-
ure S5A). The Rg value calculated from the crystal structure (55 A˚)
is smaller than that derived from the SAXS data (61 A˚) and may
reflect interconversion in solution between fully closed and
more open forms.
Ab initio shape reconstructions based on the experimental
SAXS data produce shape envelopes that recapitulate the
diameter (150 A˚) and height (100 A˚) of the crystal structure
(Figure 4D). Superposition of the crystal structure on the SAXS
envelope shows that the shape reconstruction only partially
accounts for the kinase domain positions above and below the
central midplane. Nevertheless, the dimensions of the ab initio
reconstructions are significantly smaller than the previous
SAXS and EM models for long-linker constructs (which have
at least one dimension of 200 A˚). The fact that the ab initio
reconstructions match the dimensions of the crystal structure
indicates that the compact state observed in the crystal is repre-
sented in the solution SAXS scattering data.
We measured SAXS data for short-linker holoenzyme
constructs that were mutated individually at the two conserved
docking sites in the hub domain: the b clip region (I321E) and
hub domain spur (T340E, L362E). When mutations are made in
the hub domain portion of the interface, the solution scattering
data demonstrate notable increases in the value of Rg (from
61 A˚ to 66 A˚) and changes in the scattering curve (Figure S5B).
The ab initio reconstructions produce a dramatically different
disc-like shape for these variants that is distinct from the
more compact reconstruction obtained from human short-linker
CaMKII (Figure 4D).
Linker Length Determines whether the Holoenzyme
Occupies a Compact or Extended Autoinhibited
Conformation
The extended disc-like SAXS reconstructions obtained for the
human short-linker constructs with mutations in the central hub
bear striking similarity to SAXS reconstructions obtained for
the C. elegans CaMKII holoenzyme (Figure 5A) (Rosenberg
et al., 2005). The key difference between the C. elegans CaMKII
and the human short-linker construct is that the linker is30 resi-
dues longer in theC. elegans construct (Figure S1). We collected
Figure 4. Human Short-Linker CaMKII Activation and Conformation
(A) Central hub mutation results in a decreased EC50 and a reduced nH. The human short-linker CaMKII shows high cooperativity and a mM EC50 value, whereas
a human short-linker CaMKII with central hub mutation shows noncooperative activation and a nM EC50 value. Error bars and ± terms expressed are standard
error of the mean (SEM).
(B) Autonomous activity of the long-linker CaMKII increases with the frequency of stimuli (100 ms pulse durations). Error bars and ± terms expressed are SEM.
(C) Short-linker human CaMKII autonomous activity (red) compared with autonomous activity of short-linker CaMKII with a mutation at the b clip docking
interaction (green) (350 ms pulse duration, at 2 and 3 mM CaM). Error bars and ± terms expressed are SEM.
(D) SAXS shows conversion from a compact to an extended state upon central hubmutation (green). Shape reconstructions are unchanged upon T306Vmutation
and addition of bosutinib (blue) and match the dimensions of the crystallized holoenzyme (transparent red envelope) when compared to the crystal structure
(orange).
See also Figure S4 and Figure S5.SAXS data on a sample of C. elegans CaMKII with its linker
segment deleted and observed scattering curves corresponding
to a reduced Rg value (61 A˚) and ab inito shape reconstructionsthat resemble those for the human short-linker CaMKII. Likewise,
when we measure data from human long-linker CaMKII (the
a isoform, which has an30 residue linker), we obtain scatteringCell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc. 739
Figure 5. Long-Linker CaMKII Conformation and Activity
(A) SAXS shows conversion between an extended and compact state.C. elegansCaMKII has a long linker and displays an extended SAXS reconstruction (purple,
left). Deletion of this linker results in a compact shape reconstruction (cyan) similar to that observed for human short-linker constructs (red). Human long-linker
CaMKII also shows an extended state (purple, right). Previous SAXS and FRET analyses indicate that Ca2+/CaM binding further unravels the complex to an even
more extended form (Rosenberg et al., 2005; Thaler et al., 2009).
(B) Human long-linker CaMKII activates cooperatively with a nM EC50 value, and these properties are unaffected by mutation of the central hub. Error bars
and ± terms expressed are SEM.
(C) Ca2+/CaM-dependent activation of human long-linker CaMKII shows increased cooperativity when measured under conditions of molecular crowding, which
is lost upon mutation of the docking interactions. Error bars and ± terms expressed are SEM.
See also Figure S4 and Figure S5.curves and extended shape reconstructions similar to those
obtained for the C. elegans CaMKII and the mutated human
short-linker form. The SAXS data for the C. elegans CaMKII
have been interpreted previously in terms of dimers of CaMKII
kinase domains arranged around the central hub, but direct740 Cell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc.evidence for this model is lacking (Rosenberg et al., 2005).
Previous SAXS and FRET analyses indicate that the extended
autoinhibited assembly unravels further to an even more
extended form upon Ca2+/CaM binding (Rosenberg et al.,
2005; Thaler et al., 2009).
These data suggest that the length of the linker determines the
distribution of conformations of the holoenzyme in solution, and
that changes in the linker length alter the equilibrium between the
compact form observed in the crystal structure and a more
extended disc-like form. The ability to interconvert between
compact and extended autoinhibited conformations of both
human and C. elegans forms of the enzymes suggests that this
equilibrium is a general feature of the enzyme.
The Docking of Kinase Domains onto the Central Hub
Is Also Relevant for CaMKII Isoforms with Long Linkers
Considering the high conservation of the kinase and hub
domains, we reasoned that the compact holoenzyme assembly
may also be relevant for isoforms with longer linkers. We
measured the Ca2+/CaM-dependent activation of human long-
linker CaMKII and observe a level of cooperativity similar to
that observed previously (Chao et al., 2010). When residues
important for kinase domain-central hub docking are mutated,
the Hill coefficient and the EC50 value for activation are unaf-
fected (Figure 5B).
The SAXS measurements and the activity assays described
previously were carried out under standard laboratory assay
conditions, where protein concentrations are much lower than
those found in the interior of the cell. Because the conversion
between the compact and extended forms of the CaMKII
holoenzyme involves a particularly large change in molecular
dimensions, we expect that this conformational change would
be sensitive to the density of macromolecules around the
holoenzyme. In crowded cellular environments, the total concen-
tration of protein ranges from 300–400 mg/ml (Ellis, 2001). We
measured the activation of human long-linker CaMKII under
simulated conditions of macromolecular crowding by using
100 mg/ml lysozyme and observe that the Hill coefficient for
this construct increases from 1.4 to 2.4. The increases in the
Hill coefficient and EC50 value are dependent on the concentra-
tion of crowding agent (Figure 5C; Figure S4B).
When the same measurement is performed with a mutant that
disrupts kinase docking against the central hub (I321E), we do
not observe an increased Hill coefficient, suggesting that the
increase in cooperativity is dependent on the docking interac-
tions observed in the crystal structure.
The similar levels of cooperativity observed for the human
long-linker CaMKII with and without central hub mutations
suggest that the extended SAXS conformation seen in dilute
solution is not dependent on the docking interactions visualized
in the crystal structure. Nevertheless, the fact that the Hill
coefficient and the EC50 value both respond to the central hub
mutations under crowding conditions indicates that CaMKII
holoenzymes with long linkers do sample the compact state,
but less frequently. Taken together, these data indicate that
the linker region modulates an equilibrium between compact
and extended autoinhibited states to alter the strength of
docking interactions.
Simulation of CaMKII Activation by Ca2+/CaM
Several computational analyses of CaMKII have been published
previously (see, for example, Chiba et al., 2008; Pepke et al.,
2010) but do not take explicit account of the architecture ofthe holoenzyme. One conclusion from these studies is that
a frequency-dependent response to Ca2+/CaM does not require
a multimeric holoenzyme. Sensitivity to the frequency of calcium
spikes arises naturally from the association and dissociation
rates for the interaction of Ca2+ with calmodulin, the interaction
of Ca2+/CaM with CaMKII, and the catalytic rate constant
for the phosphorylation of Thr286 on one CaMKII subunit
by another. Given these conclusions, we wondered what aspect
of the frequency-dependent behavior of CaMKII might be
dependent on the dodecameric holoenzyme.
One property of CaMKII that must be a consequence of its
assembly is the difference in frequency response that is
observed for CaMKII isoforms with linkers of different lengths
(Bayer et al., 2002). The high degree of conservation in se-
quences of the kinase domain and the regulatory segments
makes it unlikely that the kinase domains of the different iso-
forms differ significantly in their intrinsic catalytic rate constants
or in their affinity for Ca2+/CaM. And yet it is apparent that iso-
forms with longer linkers have a higher affinity for Ca2+/CaM
and acquire Ca2+-independent activity at lower frequencies
than do isoforms with shorter linkers (Bayer et al., 2002).
The results presented earlier suggest that the length of the
linker controls the equilibrium between the compact form of the
holoenzyme, in which the calmodulin-binding elements are
completely sequestered, andmore open forms. To see howalter-
ations in the equilibrium between open and closed states might
alter the frequency response, we set up a stochastic simulation
scheme (Gillespie, 1976) for themechanism of CaMKII activation
by calmodulin (Figure 6A). The holoenzyme is represented in this
scheme by 12 kinase domains arrayed around a circle, with no
distinction made between the upper and lower rings seen in the
crystal structure. In the completely autoinhibited state, each of
the kinase domains is inaccessible to Ca2+/CaM. Each kinase
domain can ‘‘pop-out’’ of the fully closed state independently
of the others, governed by kinetic rates for kinase domain
popping-out and retracting, kpop and kpop, respectively. The
equilibrium constant is the ratio of the rates, denoted Kpop. Only
the releasedkinasedomaincanbind toCa2+/CaM,anda released
kinase domain bound to Ca2+/CaM facilitates the popping-out of
two adjacent subunits and their binding to Ca2+/CaM. This
feature was introduced because the release of the regulatory
subunit from one kinase domain by Ca2+/CaM allows that kinase
domain to capture the regulatory segment of a nearby kinase
domain (Chao et al., 2010; Hoffman et al., 2011). Once two adja-
cent subunits are bound to Ca2+/CaM they can phosphorylate
each other on Thr286, leading to Ca2+-independent activity.
We simulated such a reaction scheme, using kinetic rate
constants and other parameters described previously (Chiba
et al., 2008), except for the introduction of the pop-out equilib-
rium and the ability of popped-out subunits to potentiate the
release of adjacent subunits (see Extended Experimental Proce-
dures). Calcium spike trains of varying frequency were used in
the simulations, consisting of alternating 100 ms square-wave
pulses of 500 mM Ca2+ followed by a period where the Ca2+
concentration was zero. The interval between Ca2+ pulses deter-
mined the frequency of the stimulation.
We monitored the accumulation of Thr286 phosphorylation
with time in these simulations, while varying the values of kpopCell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc. 741
Figure 6. A Stochastic Computational Model for the CaMKII Frequency Response
(A) Scheme for simulations of CaMKII’s frequency response (see Figure S7).
(B) Results for a simulation inwhich a popped-out subunit increases the popping-out probability of the adjacent subunit 5-fold and increases Ca2+/CaMbinding to
the adjacent subunit 5-fold (each simulation was run for 30 s).
Data for simulations in which cooperativity was absent are shown in Figure S7C. See also Figure S7.and kpop to change the pop-out equilibrium constant, Kpop, from
102 to 102. Results for a calmodulin concentration of 500 nMare
shown in Figure 6B (the time evolution of different species and
additional calmodulin concentrations are shown in Figure S7).
These results show clearly that the stability of the closed form
has a strong effect on the frequency response of the holoen-
zyme. When the holoenzyme is strongly biased toward the
open form (Kpop is 10 or higher), it gains substantial Ca
2+ inde-
pendence with pulse trains between 1 and 10 Hz. In contrast,
for lower values of Kpop, much less activity is seen for the742 Cell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc.same range of frequencies. This trend is alsomaintained in simu-
lations in which a popped-out subunit does not influence the
popping-out of an adjacent subunit or its ability to bind to
Ca2+/CaM (Figure S7C).
Our simulation results suggest that the interconversion
between the open and closed forms provides an additional
kinetic step in the activation of CaMKII that is readily varied
without changing the catalytic machinery or the regulatory
segment. Changes in the linker length might also change the
rate at which kinase domains can access each other for the
Figure 7. An Equilibrium between Compact and Open Autoinhibited States Sets the Frequency Threshold
The compact autoinhibited state is completely inaccessible to calmodulin due to docking against the central hub and incorporation of the regulatory segment into
the hub domain. The compact state is in equilibrium with an extended form, where the calmodulin recognition element (shown in burgundy) is accessible. Both
states are autoinhibited. Linker length alters the strength of kinase-central hub autoinhibitory interactions. Shortening the linker shifts the equilbrium toward the
compact state, setting the threshold frequency to higher values. Lengthening the linker shifts the equilibrium to the extended state, setting the threshold calcium
frequency to lower values.transphosphorylation reaction, but we have not included this in
our simulations because there is limited information on this
aspect of the reaction.
Conclusions
We have determined the structure of the CaMKII holoenzyme in
an autoinhibited state and shown how the regulation of the
enzyme involves the integration of the autoinhibitory elements
directly into the central hub that organizes the dodecameric
assembly. The structure we have determined presumably corre-
sponds to themost tightly inhibited assembly of the enzyme, and
one in which the calmodulin-binding elements cannot be ac-
cessed by calmodulin. We have shown that CaMKII undergoes
a dynamic equilibrium between this compact form and a more
extended form where the kinase domains are released from
the tight embrace of the central hub but are still autoinhibited
(Figure 7). We surmise that it is this more extended form to which
calmodulin binds, and that the response of the enzyme to the
frequency of activating calcium spikes is tuned by varying the
balance of this equilibrium. Our structure explains how CaMKII
variants with different linker lengths are all consistent with adop-
tion of either class of structures while having altered preferences
for the set-point of the equilibrium.
A basic function of the holoenzyme architecture early in evolu-
tionmayhave simplybeen toconcentrateCaMKIIwhere it ismost
needed. Once the enzyme was concentrated in this way, evolu-
tionary pressure to prevent spurious transphosphorylationwould
have become acute, and the holoenzyme assembly that we
describe here is presumably the result. Colocalization into a ho-
momultimeric assembly can provide evolutionary advantages
for evolving allosteric control (Kuriyan and Eisenberg, 2007).
The structure presented here shows that the colocalization
element itself can be used as a layer of autoinhibition. Natural
variants of the enzyme have essentially identical kinase and
central hub domains and differ mainly in the length of the linker
that controls the equilibrium between closed and open forms of
the holoenzyme. This provides a mechanism whereby modu-
lating autoinhibition tunes the calcium frequency response.EXPERIMENTAL PROCEDURES
Protein Expression and Purification
Abacterial expression system for expression of humanCaMKII was used for all
protein samples and has been described previously (Chao et al., 2010).
C. elegans constructswere prepared similarly. Full-length constructs of human
CaMKII were cloned in a pSMT-3 vector containing an N-terminal Sumo tag
(LifeSensors). Expression in Tuner(DE-3)pLysS cells was induced by addition
of 1 mM isopropyl b-D-1-thiogalactopyranoside, grown overnight at 18C. Cell
pellets were resuspended and lysed by cell disrupter. Lysate was loaded onto
a 5ml Ni-NTA column, with buffer containing 75mM imidazole, eluted with 1M
imidazole, and cleaved with Ulp1 protease or PreScission protease (for sumo
fusion or C-terminal His-tag constructs, respectively). The final samples were
buffer-exchanged by superose 6 gel-filtration chromatography (final buffer:
25 mM 1,3-bis(tris(hydroxymethyl)methylamino)propane, 150 mM potassium
chloride, 2 mM dithiothreitol, 1 mM tris(2-carboxyethyl)phosphine)).
Calmodulin (from Gallus gallus) was expressed using a pET-15b vector
(generous gift of Angus Nairn) and purified as described previously (Putkey
and Waxham, 1996).
Crystallization of the CaMKII Holoenzyme
The crystallization construct comprised residues 7–444 of human a isoform of
CaMKII with the b7 linker with mutations K42M, D135N, and T306V. Protein
samples were concentrated in the presence of 2-fold molar excess bosutinib,
which was a gift from Giulio Superti-Furga. Crystals were grown by sitting
drop vapor diffusion in 1.2 M Ammonium Tartrate, 100 mM bistrispropane
(pH 5.5) from repeated seeding. An additive (0.16% w/v 1,4-Diaminobutane,
0.16% w/v 1,8-Diaminooctane, 0.16% w/v Cadaverine, 0.16% w/v Cystamine
dihydrochloride, 0.16%w/vSpermidine,0.16%w/vSpermine, 0.02M inHEPES
sodium, pH 6.8) facilitated growth of crystals in a third dimension. Crystals were
cryoprotected in 25% glycerol. X-ray data were collected at the Advanced
Light Source beamlines 8.2.1 and 8.2.2 at 100K, at the wavelength 0.9537 A˚.
Structure Determination and Refinement
Structures were solved by molecular replacement using Phaser (McCoy et al.,
2007). Refinement was performed with CNS (Bru¨nger et al., 1998) and PHENIX
(Adams et al., 2002), and model building was performed using O (Jones et al.,
1991) and Coot (Emsley and Cowtan, 2004). For residue segments 299–304
and 309–314, the kinematic closure (KIC) method (Mandell et al., 2009)
implemented in Rosetta revision 39011 was used to generate large numbers
of potential loop models. The KIC refinement protocol was employed as
described previously (Mandell et al., 2009) except for keeping the temperature
fixed at kBT = 1.2 and sampling non-pivot phi/psi torsions from a Gaussian
distribution 3 above and below the value after the previous move.Cell 146, 732–745, September 2, 2011 ª2011 Elsevier Inc. 743
Conformations of all side-chains within 10 A˚ of either segment were optimized
after each kinematic move. Models were clustered by backbone root mean
square deviation, and the best scoring models from the five largest clusters
were compared against the electron density maps. The refined solution was
obtained from the best scoring model from the largest cluster. All modeled
residues for these regions (residues 299–304 and 309–314) were included in
the final model.
Small-Angle X-Ray Scattering
SAXS data were collected at SIBYLS beamline 12.3.1 using a Mar 165 CCD
area detector (165 mm diameter). Fifteen microliter samples were loaded in
a 1 mm thick chamber with 25 mm mica windows by an automated robotics
setup (Hura et al., 2009). Incident X-rays were tuned to a wavelength of 1.0–
1.5 A˚, and the detector to sample distance was 1.5 m, resulting in scattering
vectors ranging from 0.007 to 0.31 A˚1. The SAXS data were measured at
three protein concentrations for each sample, with no evidence for aggrega-
tion- or concentration-dependent changes in scattering curves. The values
of Rg were determined using PRIMUS (Konarev et al., 2003) and GNOM
(Svergun, 1992). Eight individual shape reconstructions were generated using
GASBOR (Svergun et al., 2001) and represented as average envelopes.
Enzyme Assays
Kinase activity was monitored using a continuous spectrophotometric assay
(Barker et al., 1995), under conditions described previously (Chao et al.,
2010). Molecular crowding measurements were performed with crowding
agents added to final concentrations of 100–200 mg/ml. Reactions were
initiated by the addition of 10–20 nM CaMKII to the mix, and the decrease in
absorbance was monitored at 340 nm and 30C in a microtiter plate spectro-
photometer (SpectraMax). Cooperativity curves were plotted and analyzed








where Y is the maximal velocity, EC50 is the concentration at half -maximal
velocity, [L] is the ligand concentration of calmodulin, and n is the apparent
Hill coefficient, nH.
Measurements of the threshold frequency for autonomous activation utilized
a pulsed-perfusion device similar to that used previously (De Koninck and
Schulman, 1998), with the radioactive assay replaced by the ADP Hunter
end-point assay (DiscoverRX). CaMKII was expressed with a C-terminal bioti-
nylation sequence (Avitag) (Howarth and Ting, 2008) and labeled using the
biotin ligase BirA (efficiency accessed by mass spectrometry to be complete).
CaMKII was loaded ontomagnetic beads coatedwith streptavidin (Dynabeads
MyOne, Invitrogen) and immobilized by a neodymiummagnet fromGaussboys
(37mmdiameter, Model C3737, pull strength 200 lbs) placed under the sample
tubing (1.58 mm diameter). Following programmed pulses of Ca2+/CaM
(500 mM calcium, 100 nM–12 mM calmodulin, 10 mM MgCl2, 250 mM ATP)
and EGTA (1 mM), the protein-labeled beads were removed from the tubing,
and autonomy was measured as a percentage of maximal Ca2+/CaM-stimu-
lated activity (in triplicate). Each frequency measurement consisted of
a 100 ms pulse of Ca2+/CaM (50 ms valve opening time) followed immediately
by a pulse of 1 mM EGTA. This sequence was repeated 60 times (total activa-
tion time, 6 s) with frequency determined by the interval between pulses.
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